Basalog 100IU/ml Injection

Product Introduction

Basalog 100IU/ml Injection is a biosimilar insulin formulation primarily used for the treatment and management of diabetes mellitus. It belongs to a class of medications known as long-acting insulins. The primary component of Basalog is insulin glargine, which is a recombinant human insulin analog. It is engineered to provide a steady, peakless, predictable release of insulin, ensuring prolonged glycemic control. Basalog is typically administered via subcutaneous injection and is designed to help in maintaining the basal level of insulin.

Basalog is produced through recombinant DNA technology which allows for the amino acid sequence modifications, elongating the action duration of the insulin. This modified insulin is dissolved in a clear aqueous fluid, making it easy to inject and monitor dosage. It comes in a variety of formulations, including vials and pre-filled pens, providing options that can accommodate patient preferences and varying medical needs.

Uses of Basalog 100IU/ml Injection

Basalog 100IU/ml Injection is primarily used in the management of diabetes mellitus for:

• Type 1 Diabetes Mellitus: It is used as a part of a basal-bolus insulin regimen where it covers the insulin needs for about 24 hours. The patient must also use short-acting insulin to manage the blood glucose spikes that occur during meals.
• Type 2 Diabetes Mellitus: In patients who are unable to achieve desired glucose control with oral hypoglycemic agents, Basalog provides a means to enhance basal insulin levels, often in combination with other insulins or oral diabetic medications.
• Gestational Diabetes: Sometimes prescribed for managing blood sugar levels in pregnant women diagnosed with gestational diabetes, if dietary modifications alone are insufficient.

The consistent and extended absorption profile of Basalog helps in mimicking the natural basal insulin secretion by the pancreas, thereby aiding in better glycemic control without frequent dosing.

Benefits of Basalog 100IU/ml Injection

The benefits of using Basalog 100IU/ml Injection include:

• Sustained Glycemic Control: By providing a continuous and steady action, Basalog helps in maintaining a stable blood glucose level throughout the day and night, which is crucial for the overall management of diabetes.
• Reduced Risk of Hypoglycemia: The peakless nature of Basalog’s action profile reduces the risks of both daytime and nocturnal hypoglycemia, a common side effect associated with many insulin therapies.
• Flexibility in Dosing: Basalog can be administered at any time of the day, but it is advisable to take it at the same time every day to maintain the best control over blood sugar levels.
• Improved Patient Compliance: The option to use it in pen form makes it convenient for self-administration, encouraging better adherence to treatment regimens.

Side Effects of Basalog 100IU/ml Injection

While Basalog is effective in managing diabetes, it can have some side effects. The most common side effects include:

• Hypoglycemia: The most significant risk associated with any insulin therapy is low blood sugar levels, which can manifest as shaking, sweating, intense hunger, palpitations, and confusion. It is important to monitor blood sugar levels regularly and adjust the dosage as necessary.
• Injection Site Reactions: Patients might experience pain, redness, itching, or swelling at the injection site. These symptoms usually resolve on their own but if they persist, a consultation with a healthcare provider may be necessary.
• Weight Gain: As with many insulin therapies, there may be an associated weight gain due to the anabolic effects of insulin and the decrease in glucosuria.
• Allergic Reactions: Rarely, systemic allergic reactions might occur, which can be severe. Symptoms include rash, difficulty breathing, or a fast heartbeat, requiring immediate medical attention.